Editorial Policies

Focus and Scope

Indonesian Journal of Cancer Chemoprevention (IJCC) is an open access, peer-reviewed, triannual journal devoted to publish articles on cancer chemoprevention including Experimental and Clinical Pharmacology, especially concerning anti-oxidants, anti-aging, anti-inflammation, anti-angiogenesis, and anti-carcinogenesis; Cancer Detection; Stem Cell Biology; Immunology; in vitro and in silico Exploration of Chemopreventive Mechanism; and Natural Products.

IJCC is an official journal of the Indonesian Society for Cancer Chemoprevention.


Section Policies

Research Article

Research Article should consist of no more than 3,500 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than six figures and/or tables in total and no more than 40 references.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review Article

Review Article should consist of no more than 10,000 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than six figures and/or tables in total and no more than 200 references.

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

All manuscripts submitted to Indonesian Journal of Cancer Chemoprevention (IJCC) will be selected and double-blind peer-reviewed by 2 or more reviewers when necessary, to present valuable and authentic findings. All details will also be reviewed, including appropriate title; content reflecting abstract; concise writing; clear purpose, study method and figures and/or tables; and summary supported by content. The reviewing process will take 2-3 months depends on the sufficiency of the information provided.

Peer-reviewers were selected based on their specialties that fit the topic. Additional reviewer/s can also be pointed when necessary. The author can suggest reviewer/s that not having publication together within five years and should not be member/s of the same research institution.


Publication Frequency

Indonesian Journal of Cancer Chemoprevention is published triannually (in February, June and October).


Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, or to use them for any other lawful purpose.



This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...


Plagiarism Screening Policy

All manuscripts submitted to Indonesian Journal of Cancer Chemoprevention will be screened for plagiarism by using Turnitin and/or Crossref Similarity Check.


Content Licensing

All materials are free to be copied and redistributed in any medium or format. However, appropriate credit should be given. The material may not be used for commercial purposes. This content licensing is in accordance with a CC license: CC-BY-NC.


Conflict of Interest Policy

Author’s Conflict of Interest 

At the point of submission, Indonesian Journal of Cancer Chemoprevention requires that each author reveals any personal and/or financial interests or connections, direct or indirect, or other situations that might raise the question of bias in work reported or the conclusions, implications, or opinions stated. When considering whether you should declare a conflicting interest or connection, please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it? 

Corresponding authors are responsible for confirming whether they or their co-authors have any conflicts of interest to declare and to provide details of these. The statement includes any information regarding whether the manuscript is under consideration for other publication, or whether you have any patents that relevant to the manuscript. If the manuscript is published, any conflict of interest information will be written in the Conflict of Interest statement.

Author’s Acknowledgement

Authors whose manuscripts are submitted for publication must declare all relevant sources of funding in support of the preparation of a manuscript. Indonesian Journal of Cancer Chemoprevention requires full disclosure of financial support as to whether it is from government agencies, the pharmaceutical or any other industry, or any other source. Authors are required to specify sources of funding for the study and to indicate whether or not the manuscript was reviewed by the sponsor before submission. This information should be included in the Acknowledgements section of the manuscript.

In addition to disclosure of direct financial support to the authors or their laboratories and prior sponsor-review of the paper, corresponding authors will be asked to disclose all relevant consultancies since the views expressed in the contribution could be influenced by the opinions they have expressed privately as consultants. This information should also be included in the Acknowledgments section of the manuscript.

Reviewer’s Conflict of Interest

Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript and should recuse themselves from reviewing specific manuscripts if the potential for bias exists. As in the case of authors, silence on the part of reviewers concerning potential conflicts may mean either that such conflicts exist that they have failed to disclose, or that conflicts do not exist. Reviewers must not use information of the manuscript they are reviewing before it is being published, furthering their interests. 


Protection of Human Subject and Animal in Research Policy

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the World Medical Association Declaration of Helsinki. If doubt exists whether the research was conducted in accordance with the said declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed. Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare.


Informed Consent Policy

Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Authors should disclose to these patients whether any potentially identifiable material might be available via the internet as well as in print after publication. Nonessential identifying details should be omitted.

Indonesian Journal of Cancer Chemoprevention decides that patient confidentiality is better guarded by having the authors archive the consent, and instead providing us with a written statement in the manuscript attesting that they have received and archived written patient consent. When informed consent has been obtained, it should be indicated later in the published article.


Role of Journal Editor

Editors of Indonesian Journal of Cancer Chemoprevention have responsibilities toward the authors who provide the content of the journals, the peer reviewers who comment on the suitability of manuscripts for publication, also toward the journal’s readers and the scientific community. Editors are responsible for monitoring and ensuring the fairness, timeliness, thoroughness, and civility of the peer-review and other editorial processes.

Peer review by external reviewers with the proper expertise is the most common method to ensure manuscript quality. However, our editors may sometimes reject manuscripts without external peer review to make the best use of their resources. Reasons for this practice are usually that the manuscript is outside the scope of Indonesian Journal of Cancer Chemoprevention, does not meet our quality standards or lacks originality or novel information.

Editor Responsibilities toward Authors

  • Providing guidelines to authors for preparing and submitting manuscripts
  • Providing a clear statement of the Journal’s policies on authorship criteria
  • Treating all authors with fairness, courtesy, objectivity, honesty, and transparency
  • Establishing and defining policies on conflicts of interest for all involved in the publication process, including editors, staff, authors, and reviewers
  • Protecting the confidentiality of every author’s work
  • Establishing a system for effective and rapid peer review
  • Making editorial decisions with reasonable speed and communicating them in a clear and constructive manner
  • Being vigilant in avoiding the possibility of editors and/or referees delaying a manuscript for suspect reasons
  • Establishing a procedure for reconsidering editorial decisions
  • Describing, implementing, and regularly reviewing policies for handling ethical issues and allegations or findings of misconduct by authors and anyone involved in the peer review process
  • Informing authors of solicited manuscripts that the submission will be evaluated according to the journal’s standard procedures or outlining the decision-making process if it differs from those procedures
  • Clearly communicating all other editorial policies and standards

Editor Responsibilities toward Reviewers

  • Assigning papers for review appropriate to each reviewer’s area of interest and expertise
  • Establishing a process for reviewers to ensure that they treat the manuscript as a confidential document and complete the review promptly
  • Informing reviewers that they are not allowed to make any use of the work described in the manuscript or to take advantage of the knowledge they gained by reviewing it before publication
  • Providing reviewers with written, explicit instructions on the journal’s expectations for the scope, content, quality, and timeliness of their reviews to promote thoughtful, fair, constructive, and informative critique of the submitted work
  • Requesting that reviewers identify any potential conflicts of interest and asking that they recuse themselves if they cannot provide an unbiased review
  • Allowing reviewers appropriate time to complete their reviews
  • Requesting reviews at a reasonable frequency that does not overtask any reviewer
  • Finding ways to recognize the contributions of reviewers, for example, by publicly thanking them in the journal; providing letters that might be used in applications for academic promotion; offering professional education credits; or inviting them to serve on the editorial board of the journal
  • Making a final decision regarding a submission status after receiving review result from reviewers

Editor Responsibilities toward Readers and the Scientific Community

  • Evaluating all manuscripts considered for publication to make certain that each provides the evidence readers need to evaluate the authors’ conclusions and that authors’ conclusions reflect the evidence provided in the manuscript
  • Providing literature references and author contact information so interested readers may pursue further discourse
  • Requiring the corresponding author to review and accept responsibility for the content of the final draft of each paper
  • Maintaining the journal’s internal integrity (e.g., correcting errors; clearly identifying and differentiating types of content, such as reports of original data, corrections/errata, retractions, supplemental data, and promotional material or advertising; and identifying published material with proper references)
  • Ensuring that all involved in the publication process understand that it is inappropriate to manipulate citations by, for example, demanding that authors cite papers in the journal
  • Disclosing all relevant potential conflicts of interest of those involved in considering a manuscript or affirming that none exist
  • Working with the publisher to attract the best manuscripts and research that will be of interest to readers


Correction and Retraction Policy

Permanency of Content 

All articles published in Indonesian Journal of Cancer Chemoprevention receive a DOI and are permanently published. In order to maintain the integrity and the completeness of the scholarly record, we will apply the following policies when published content needs to be corrected. These policies take into account current best practice in the scholarly publishing and library communities: 

1. Correction to an Article 

Occasionally, Indonesian Journal of Cancer Chemoprevention may correct or amplify a previously-published article by republishing the article in its entirety, often to rectify an editorial or printing error in the original article.

Referring to ‘Retraction: Guidance from the Committee on Publication Ethics (COPE)’, an article may be corrected for several reasons, including:

  • it contains minor errors in article design,
  • it contains a small portion of an otherwise reliable publication proves to be misleading (especially because of honest error)
  • the author/contributor list is incorrect (i.e. a deserving author has been omitted or somebody who does not meet authorship criteria has been included)  

2. Retraction to an Article 

Retraction is a mechanism for removing the literature and alerting readers to publications that contain such seriously flawed or erroneous data that their findings and conclusions cannot be relied upon. Unreliable data may result from honest error or from research misconduct. The main purpose of retractions is to correct the literature and ensure its integrity rather than to punish authors who misbehave.

Referring to ‘Retraction: Guidance from the Committee on Publication Ethics (COPE)’, articles in Indonesian Journal of Cancer Chemoprevention may be retracted for several reasons, including:

  • it is found with clear evidence that the article is a result of misconduct (e.g. data fabrication) or honest error (e.g. miscalculation or experimental error),
  • the article or the data contained in the article have previously been published elsewhere without proper crossref referencing permission or justification (i.e. cases of redundant publication),
  • it constitutes plagiarism,
  • it reports unethical research or has a failure to disclose a major competing interest.